Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001535610-17-000097
Filing Date
2017-12-14
Accepted
2017-12-14 09:40:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 SABBY 13G VTGN 12.14.17 vtgn1217.txt SC 13G 11759
  Complete submission text file 0001535610-17-000097.txt   13379
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Subject) CIK: 0001411685 (see all company filings)

EIN.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: SC 13G | Act: 34 | File No.: 005-86249 | Film No.: 171255283
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10 MOUNTAINVIEW ROAD SUITE 205 UPPER SADDLE RIVER NJ 07458
Business Address 10 MOUNTAINVIEW ROAD SUITE 205 UPPER SADDLE RIVER NJ 07458 646-307-4527
SABBY MANAGEMENT, LLC (Filed by) CIK: 0001535610 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G